1.
Al-Omari YW, Mustafa SA, Saleh AH, Abdel-Razaq WS. Bleeding disorder, a newly recognized adverse event following sacubitril/valsartan therapy. EJCRIM [Internet]. 2026 Mar. 11 [cited 2026 Nov. 18];13(4). Available from: https://ojs.wedare.app/ejcrim/article/view/6178